Detalles de la búsqueda
1.
Trends in overall mortality among US veterans with primary myelofibrosis.
BMC Cancer;
23(1): 48, 2023 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641455
2.
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Oncologist;
27(10): 874-883, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972334
3.
Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval.
Ann Hematol;
101(1): 131-137, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625831
4.
Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
26(3): 600-605, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678539
5.
Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
Support Care Cancer;
28(11): 5491-5499, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32172407
6.
Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey.
Ann Hematol;
98(5): 1119-1125, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30694363
7.
Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data.
Ann Hematol;
98(11): 2533-2539, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31552445
8.
Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: results from the living with MPNs survey.
BMC Cancer;
18(1): 420, 2018 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653557
9.
Cytoreductive treatment patterns among US veterans with polycythemia vera.
BMC Cancer;
18(1): 528, 2018 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728092
10.
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.
Cancer;
123(3): 449-458, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690182
11.
Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy.
Eur J Haematol;
97(2): 192-200, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26608702
12.
Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
J Gen Intern Med;
28(5): 691-7, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23345072
13.
Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
J Med Econ;
26(1): 454-462, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883994
14.
Treatment preferences among patients with mild-to-moderate atopic dermatitis.
J Dermatolog Treat;
34(1): 2215356, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259544
15.
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs.
J Med Econ;
26(1): 843-849, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294103
16.
Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States.
Leuk Lymphoma;
63(3): 694-702, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689695
17.
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia.
Leuk Res;
115: 106809, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220060
18.
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years.
Ann Rheum Dis;
70(9): 1631-40, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21708910
19.
Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.
Clin Lymphoma Myeloma Leuk;
21(11): e915-e921, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353779
20.
Healthcare resource utilization and costs among patients with steroid-resistant chronic graft-versus-host disease in the United States: a retrospective claims database analysis.
Curr Med Res Opin;
37(5): 755-759, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615925